IndiTreat® to be distributed in Czech Republic and Slovakia
-
IndiTreat
to be distributed in Czech Republic and Slovakia through Promedica
2cureX, a company pioneering the use of 3D tumoroids for drug sensitivity prediction in patients with cancer, announced today that Promedica Prague Group, the largest independent healthcare distributor in the Czech Republic, will bring IndiTreat products to Czech and Slovakian patients and professionals. This new collaboration agreement brings the total of 2cureX partners to 9, covering 14 European countries and a combined population of 235 million people.
2cureX and Promedica Prague Group have signed an agreement by which Promedica Prague Group becomes the distributor of IndiTreat products in Czech Republic and Slovakia. Under the terms of the collaboration, Promedica Prague Group will promote IndiTreat to oncology professionals, sign supply agreements with hospitals and manage the sample logistics between the hospitals and 2cureX labs in Copenhagen.IndiTreat
present in 14 countries -
De begynder virkelig at få foden indenfor i mange lande efterhånden....utrolig spændende firma, med styr på omkostningerne.
-
Analyse fra Mangold... https://www.2curex.com/wp-content/uploads/2cureX_update_2021-10-29.pdf
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind